JP2023522693A5 - - Google Patents

Info

Publication number
JP2023522693A5
JP2023522693A5 JP2022563376A JP2022563376A JP2023522693A5 JP 2023522693 A5 JP2023522693 A5 JP 2023522693A5 JP 2022563376 A JP2022563376 A JP 2022563376A JP 2022563376 A JP2022563376 A JP 2022563376A JP 2023522693 A5 JP2023522693 A5 JP 2023522693A5
Authority
JP
Japan
Prior art keywords
carbonyl
pyrimidine
amino
pyrazolo
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022563376A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522693A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/028381 external-priority patent/WO2021216696A1/en
Publication of JP2023522693A publication Critical patent/JP2023522693A/ja
Publication of JP2023522693A5 publication Critical patent/JP2023522693A5/ja
Priority to JP2025187946A priority Critical patent/JP2026027386A/ja
Pending legal-status Critical Current

Links

JP2022563376A 2020-04-22 2021-04-21 Ｂｔｋ阻害剤を使用するサイトカインストームを包含する急性呼吸窮迫症候群および他の障害の処置 Pending JP2023522693A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025187946A JP2026027386A (ja) 2020-04-22 2025-11-07 Ｂｔｋ阻害剤を使用するサイトカインストームを包含する急性呼吸窮迫症候群および他の障害の処置

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063013784P 2020-04-22 2020-04-22
US63/013,784 2020-04-22
PCT/US2021/028381 WO2021216696A1 (en) 2020-04-22 2021-04-21 Treatment of acute respiratory distress syndrome and other disorders involving cytokine storm using btk inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025187946A Division JP2026027386A (ja) 2020-04-22 2025-11-07 Ｂｔｋ阻害剤を使用するサイトカインストームを包含する急性呼吸窮迫症候群および他の障害の処置

Publications (2)

Publication Number Publication Date
JP2023522693A JP2023522693A (ja) 2023-05-31
JP2023522693A5 true JP2023522693A5 (enExample) 2024-05-01

Family

ID=75919390

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022563376A Pending JP2023522693A (ja) 2020-04-22 2021-04-21 Ｂｔｋ阻害剤を使用するサイトカインストームを包含する急性呼吸窮迫症候群および他の障害の処置
JP2025187946A Pending JP2026027386A (ja) 2020-04-22 2025-11-07 Ｂｔｋ阻害剤を使用するサイトカインストームを包含する急性呼吸窮迫症候群および他の障害の処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025187946A Pending JP2026027386A (ja) 2020-04-22 2025-11-07 Ｂｔｋ阻害剤を使用するサイトカインストームを包含する急性呼吸窮迫症候群および他の障害の処置

Country Status (12)

Country Link
US (1) US20230158031A1 (enExample)
EP (1) EP4138836A1 (enExample)
JP (2) JP2023522693A (enExample)
KR (1) KR20230015346A (enExample)
CN (1) CN115443136A (enExample)
AU (1) AU2021261327A1 (enExample)
BR (1) BR112022020974A2 (enExample)
CA (1) CA3175788A1 (enExample)
IL (1) IL297316A (enExample)
MX (1) MX2022013164A (enExample)
TW (1) TW202206076A (enExample)
WO (1) WO2021216696A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120617259B (zh) * 2025-06-05 2026-04-10 南昌大学第一附属医院 Btk protac化合物nx-5948的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
PL2710005T3 (pl) * 2011-05-17 2017-07-31 Principia Biopharma Inc. Inhibitory kinazy tyrozynowej
EP2773639B1 (en) * 2011-11-03 2017-04-26 F. Hoffmann-La Roche AG Alkylated piperazine compounds as inhibitors of btk activity
SI2892900T1 (en) 2012-09-10 2018-01-31 Principia Biopharma Inc. Pyrazolopyrimidine compounds as kinase inhibitors
WO2015095099A1 (en) * 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Btk inhibitors
WO2015149056A1 (en) * 2014-03-28 2015-10-01 Board Of Regents, The University Of Texas System Inhibition of bruton's tyrosine kinase (btk) in the lung to treat severe lung inflammation and lung injury
WO2016106625A1 (en) * 2014-12-31 2016-07-07 Merck Sharp & Dohme Corp. Btk inhibitors
WO2021211782A1 (en) * 2020-04-15 2021-10-21 Telios Pharma, Inc. Methods of treating acute lung injury and acute respiratory distress syndrome

Similar Documents

Publication Publication Date Title
US12559473B2 (en) Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
US20260098036A1 (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
JP2017511365A5 (enExample)
TW201725202A (zh) 新穎經取代吲唑、其製法、包含其之醫藥製劑及其製備藥劑之用途
JP2022534751A5 (enExample)
JP2022542396A5 (enExample)
JP2005538099A5 (enExample)
JP2011504497A5 (enExample)
RU2009136299A (ru) Новые производные 3-({1,2,4}триазоло{4,3-а}пиридин-7-ил)бензамида
RU2008144584A (ru) 4,5-дигидро-[1,2,4]триазоло[4,3-f]птеридины в качестве ингибиторов протеинкиназы plk1 для лечения пролиферативных заболеваний
JP2014531449A5 (enExample)
MX2013005305A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis.
JP2005536475A5 (enExample)
JP2014505735A5 (enExample)
RU2006126974A (ru) Амидное производное и лекарственное средство
RU2017135520A (ru) Бициклические производные хиназолинона
CN101969951A (zh) 治疗关节炎的方法
RU2015117949A (ru) Ингибиторы тирозинкиназы брутона
JP2018522861A5 (enExample)
JP2017501983A5 (enExample)
JP2018512408A5 (enExample)
JP2017525721A (ja) 認知欠損または認知障害に伴って進行する神経障害のおよび神経変性疾患の処置および予防のための製品
JP2019502686A5 (enExample)
JP2017538697A5 (enExample)
JP2006512366A5 (enExample)